LEVEL FOUR ADVISORY SERVICES, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1696715 DALLAS, TX

Position in REGN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$246,921

-$444,591 QoQ

Shares Held

396

-55.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#993

of 1,329 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LEVEL FOUR ADVISORY SERVICES, LLC holds $9,160,165 across 9 Biotechnology names. REGN ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	10,034	$4,984,188
2	GMAB	Genmab A/S	58,000	$1,593,260
3	ARGX	Argenx SE	1,148	$1,065,079
4	JAZZ	Jazz Pharmaceuticals plc	3,490	$840,985
5	TVTX	Travere Therapeutics, Inc.	5,506	$312,795
6	REGN	Regeneron Pharmaceuticals, Inc. This page	396	$246,921
7	MNKD	Mannkind Corp	21,338	$90,899
8	OCGN	Ocugen, Inc.	17,000	$26,010

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$246,921	396	-55.8%	Shares	Sole	2026-08-10
2026-03-31	$691,512	895	-6.0%	Shares	Sole	2026-05-14
2025-12-31	$734,820	952	+65.3%	Shares	Sole	2026-02-13
2023-09-30	$474,024	576	+21.0%	Shares	Sole	2023-11-13
2023-06-30	$342,025	476	+75.6%	Shares	Sole	2023-07-10
2023-03-31	$222,672	271	-8.1%	Shares	Sole	2023-06-05
2022-12-31	$212,839	295	+1.0%	Shares	Sole	2023-02-13
2022-09-30	$201,150	292	-18.2%	Shares	Sole	2022-11-07
2022-06-30	$211,033	357	-27.4%	Shares	Sole	2022-08-08
2022-03-31	$343,622	492	+32.3%	Shares	Sole	2022-05-10
2021-12-31	$234,925	372	-89.9%	Shares	Sole	2022-02-11
2021-06-30	$2,049,841	3,670	—	Shares	Sole	2021-08-09
No filing history on record for this holder in this stock.